457 related articles for article (PubMed ID: 17577100)
1. Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.
Bao W; Behm DJ; Nerurkar SS; Ao Z; Bentley R; Mirabile RC; Johns DG; Woods TN; Doe CP; Coatney RW; Ohlstein JF; Douglas SA; Willette RN; Yue TL
J Cardiovasc Pharmacol; 2007 Jun; 49(6):362-8. PubMed ID: 17577100
[TBL] [Abstract][Full Text] [Related]
2. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla.
Chan SH; Hsu KS; Huang CC; Wang LL; Ou CC; Chan JY
Circ Res; 2005 Oct; 97(8):772-80. PubMed ID: 16151022
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial dysfunction and superoxide anion production in heart failure are p38 MAP kinase-dependent.
Widder J; Behr T; Fraccarollo D; Hu K; Galuppo P; Tas P; Angermann CE; Ertl G; Bauersachs J
Cardiovasc Res; 2004 Jul; 63(1):161-7. PubMed ID: 15194473
[TBL] [Abstract][Full Text] [Related]
4. Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation.
Li JM; Wheatcroft S; Fan LM; Kearney MT; Shah AM
Circulation; 2004 Mar; 109(10):1307-13. PubMed ID: 14993144
[TBL] [Abstract][Full Text] [Related]
5. Hypertensive target organ damage is attenuated by a p38 MAPK inhibitor: role of systemic blood pressure and endothelial protection.
Olzinski AR; McCafferty TA; Zhao SQ; Behm DJ; Eybye ME; Maniscalco K; Bentley R; Frazier KS; Milliner CM; Mirabile RC; Coatney RW; Willette RN
Cardiovasc Res; 2005 Apr; 66(1):170-8. PubMed ID: 15769460
[TBL] [Abstract][Full Text] [Related]
6. IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy.
Schrader LI; Kinzenbaw DA; Johnson AW; Faraci FM; Didion SP
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2576-81. PubMed ID: 17962626
[TBL] [Abstract][Full Text] [Related]
7. p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1. p38 MAPK-dependent endothelial dysfunction and hypertension.
Ju H; Behm DJ; Nerurkar S; Eybye ME; Haimbach RE; Olzinski AR; Douglas SA; Willette RN
J Pharmacol Exp Ther; 2003 Dec; 307(3):932-8. PubMed ID: 14561851
[TBL] [Abstract][Full Text] [Related]
8. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
9. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase.
Sarr M; Chataigneau M; Martins S; Schott C; El Bedoui J; Oak MH; Muller B; Chataigneau T; Schini-Kerth VB
Cardiovasc Res; 2006 Sep; 71(4):794-802. PubMed ID: 16822492
[TBL] [Abstract][Full Text] [Related]
10. Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice.
Virdis A; Iglarz M; Neves MF; Amiri F; Touyz RM; Rozen R; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1352-7. PubMed ID: 12829522
[TBL] [Abstract][Full Text] [Related]
11. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
[TBL] [Abstract][Full Text] [Related]
12. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation.
Cruzado MC; Risler NR; Miatello RM; Yao G; Schiffrin EL; Touyz RM
Am J Hypertens; 2005 Jan; 18(1):81-7. PubMed ID: 15691621
[TBL] [Abstract][Full Text] [Related]
13. NADPH oxidase is involved in angiotensin II-induced apoptosis in H9C2 cardiac muscle cells: effects of apocynin.
Qin F; Patel R; Yan C; Liu W
Free Radic Biol Med; 2006 Jan; 40(2):236-46. PubMed ID: 16413406
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase.
Qamirani E; Ren Y; Kuo L; Hein TW
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):995-1001. PubMed ID: 15718491
[TBL] [Abstract][Full Text] [Related]
15. Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice.
Matsuno K; Yamada H; Iwata K; Jin D; Katsuyama M; Matsuki M; Takai S; Yamanishi K; Miyazaki M; Matsubara H; Yabe-Nishimura C
Circulation; 2005 Oct; 112(17):2677-85. PubMed ID: 16246966
[TBL] [Abstract][Full Text] [Related]
16. Superoxide anion mediates angiotensin II-induced potentiation of contractile response to sympathetic stimulation.
Lu C; Su LY; Lee RM; Gao YJ
Eur J Pharmacol; 2008 Jul; 589(1-3):188-93. PubMed ID: 18538762
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of p38 mitogen-activated protein kinase and cyclooxygenase 2 inhibitors in a model of cardiovascular disease.
Willette RN; Eybye ME; Olzinski AR; Behm DJ; Aiyar N; Maniscalco K; Bentley RG; Coatney RW; Zhao S; Westfall TD; Doe CP
J Pharmacol Exp Ther; 2009 Sep; 330(3):964-70. PubMed ID: 19556450
[TBL] [Abstract][Full Text] [Related]
18. Rac1 mediates sex difference in cardiac tumor necrosis factor-alpha expression via NADPH oxidase-ERK1/2/p38 MAPK pathway in endotoxemia.
Zhu H; Shan L; Peng T
J Mol Cell Cardiol; 2009 Aug; 47(2):264-74. PubMed ID: 19450605
[TBL] [Abstract][Full Text] [Related]
19. Role of neuronal NO synthase in regulating vascular superoxide levels and mitogen-activated protein kinase phosphorylation.
Zhang GX; Kimura S; Murao K; Shimizu J; Matsuyoshi H; Takaki M
Cardiovasc Res; 2009 Feb; 81(2):389-99. PubMed ID: 18987049
[TBL] [Abstract][Full Text] [Related]
20. A novel p38 MAPK target dyxin is rapidly induced by mechanical load in the heart.
Luosujärvi H; Aro J; Tokola H; Leskinen H; Tenhunen O; Skoumal R; Szokodi I; Ruskoaho H; Rysä J
Blood Press; 2010 Feb; 19(1):54-63. PubMed ID: 20175653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]